Biotalys completes its €47.5m initial public offering on Euronext Brussel
KBC Securities is happy to announce the successful closing for Biotalys of its €47.5 million IPO, or €54.6 million, assuming the exercise in full of the Over-allotment Option, with the admission of all of its shares to trading on the regulated market of Euronext Brussels.
Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for a more sustainable and safer food supply. Biotalys’ shares will trade under the symbol “BLTS”.
In a more challenging IPO market environment, the orderbook was built with strong support from high-quality long-term institutional investors across Europe and retail investors in Belgium.
Transaction highlights:
Issue price: €7.50 per share
Base offering: 6,333,333 new shares
Over-allotment option: 949,999 new shares
The implied market capitalization of Biotalys is approximately €232.3 million (if the over-allotment option is fully exercised)
The proceeds of the transaction allow Biotalys to support its mission to shape the future of sustainable and safe food supply
KBC Securities is very proud that it had the opportunity to support this sustainability story in its further growth!
Furthermore, this operation reinforces KBC Securities’ market leadership position in terms of Equity Capital Market transactions in Belgium. It is alreadyits 2nd IPO, following the IPO of the ESG-driven off-grid water solution company Ekopak in March 2021, and its 13th equity transaction on Euronext Brussels year-to-date that KBC Securities is involved in.